Company Overview of AAA Canada
AAA Canada, a biopharmaceutical company, develops in-vivo radiopharmaceutical products suitable for nuclear medicine imaging and for positron emission tomography imaging. The company offers a lyophilized kit for the preparation of Tc-99m labeled V-128 Annexin, a form of Annexin with a peptide tail, which avidly binds the imaging isotope. Its product aids in the early diagnosis and management of diseases, including rheumatoid arthritis. AAA Canada was formerly known as Atreus Pharmaceuticals Corporation and changed its name to AAA Canada. The company was founded in 2007 and is based in Ottawa, Canada.
9 Hansen Avenue
Ottawa, ON K2K-2L9
Founded in 2007
Key Executives for AAA Canada
Similar Private Companies By Industry
|Advanced Solutions & Technologies Inc.||Americas|
|GenomeDx Biosciences Inc.||Americas|
|Augurex Life Sciences Corp.||Americas|
|Triphase Accelerator Corporation||Americas|
|Turnstone Biologics Inc.||Americas|
Recent Private Companies Transactions
January 8, 2015
To contact AAA Canada, please visit www.atreuspharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.